文献速递甲状腺与浅表US

中国甲状腺影像报告与数据系统联合超声造影评分鉴别甲状腺结节良恶性的价值

The Value of Chinese Thyroid Imaging Report and Data System Combined With Contrast-Enhanced Ultrasound Scoring in Differential Diagnosis of Benign and Malignant Thyroid Nodules.
PubMed 文献 · J Ultrasound Med · 2021-10-28

本研究回顾性分析355例患者388个甲状腺结节的常规超声和超声造影资料,以病理为金标准,发现动脉期轻度增强和快退是恶性指标,等退是良性指标;C-TIRADS联合超声造影评分的AUC为0.877,高于单独C-TIRADS的0.840,提示联合评分对鉴别甲状腺结节良恶性有更高价值。

要点

  • 超声造影动脉期轻度增强和快退提示恶性,等退提示良性。
  • C-TIRADS联合超声造影评分的AUC为0.877,高于单独C-TIRADS的0.840。
  • 联合评分最佳诊断界值为2分,敏感度89.7%、特异度72.9%。

关键影像表现/征象

  • 超声造影观察指标包括动脉期增强程度(无增强、稀疏点线状增强、轻度增强、中度增强、高度增强)和消退模式(快退、慢退、等退)。
  • 动脉期轻度增强和快退是恶性指标(各+1分),等退是良性指标(-1分)。

诊断标准与关键数值

  • C-TIRADS评分与C-TIRADS联合超声造影评分鉴别良恶性的最佳诊断界值均为2分。
  • C-TIRADS评分敏感度79.97%、特异度75.48%、阳性预测值82.9%、阴性预测值70.5%。
  • C-TIRADS联合超声造影评分敏感度89.7%、特异度72.9%、阳性预测值83.3%、阴性预测值82.5%。
  • C-TIRADS评分AUC为0.840,联合评分AUC为0.877(P < .001)。

临床应用与阅片要点

  • 对甲状腺结节行超声造影时,关注动脉期增强程度和消退模式,轻度增强和快退应警惕恶性。
  • 可将超声造影恶性指标(轻度增强、快退)和良性指标(等退)纳入C-TIRADS评分体系进行联合评分。
  • 联合评分最佳界值为2分,可作为鉴别良恶性的参考阈值。

局限性

  • 本研究为回顾性分析,可能存在选择偏倚。
  • 样本仅来自单中心,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To explore the diagnostic value of contrast-enhanced ultrasound (CEUS) combined with the Chinese Thyroid Imaging Reporting and Data System (C-TIRADS) for differentiation of benign and malignant thyroid nodules.

METHODS: A retrospective analysis of the conventional ultrasound and CEUS data of 388 nodules in 355 patients who had undergone thyroid nodule resection was conducted. All nodules had clear pathological results. The CEUS observation indexes included the enhancement degree in the arterial phase (no enhancement, scant punctate-linear enhancement, mild enhancement, moderate enhancement, and high enhancement) and wash-out patterns (rapid wash-out, slow wash-out, and isochronous wash-out). Chi-square test between groups and receiver operating characteristic curves (ROC) were used to determine the malignant (+1 point) and benign (-1 point) observation indexes that were statistically significant for the differentiation between benign and malignant thyroid nodules. The CEUS and C-TIRADS malignant and benign indexes were combined to score and draw the ROC curve, which was compared with the ROC curve scored by C-TIRADS alone to compare the diagnostic efficacy of the two methods for differentiating between benign and malignant thyroid nodules.

RESULTS: Among the CEUS observation indexes, mild enhancement and rapid wash-out were malignant indexes, while isochronous wash-out was a benign index. The best diagnostic cut-off value for the differentiation of benign and malignant thyroid nodules using the C-TIRADS score and the C-TIRADS and CEUS combined score (C-TIRADS + CEUS score) was 2. The sensitivity, specificity, positive predictive values (PPV), and negative predictive values (NPV) of the two methods were 79.97, 75.48, 82.9, 70.5%, and 89.7, 72.9, 83.3, 82.5%, respectively. The area under the curve values were 0.840 and 0.877 (P < .001), respectively.

CONCLUSIONS: The CEUS feature of mild enhancement in the arterial phase and rapid wash-out pattern are suggestive of malignancy and isochronous wash-out pattern is suggestive of benignity. The C-TIRADS + CEUS score has a higher value for distinguishing benign from malignant thyroid nodules than the C-TIRADS score alone.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Cao H, Fan Q, Zhuo S, et al. The Value of Chinese Thyroid Imaging Report and Data System Combined With Contrast-Enhanced Ultrasound Scoring in Differential Diagnosis of Benign and Malignant Thyroid Nodules. J Ultrasound Med. 2021. PMID: 34709672. doi:10.1002/jum.15858

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。